Invenomic Capital Management’s Ingredion INGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.9M Sell
220,493
-40,178
-15% -$4.25M 1.25% 27
2026
Q1
$29.4M Buy
260,671
+109,294
+72% +$12.5M 1.35% 25
2025
Q4
$16.7M Buy
+151,377
New +$17.1M 0.78% 46
2022
Q3
Sell
-127,342
Closed -$11.2M 168
2022
Q2
$11.2M Buy
127,342
+97,540
+327% +$8.73M 0.8% 41
2022
Q1
$1.47M Buy
+29,802
New +$2.7M 0.16% 115

Other funds holding INGR

Invenomic Capital Management's INGR Position: Q2 2026 in Review

Invenomic Capital Management reduced its Ingredion (INGR) stake by 15% in Q2 2026, selling an estimated $4.25M and leaving 220,493 shares worth $20.9M. The position accounts for 1.25% of the portfolio, ranked #27.

Invenomic Capital Management first reported a position in INGR in Q1 2022 and has held it in 5 quarters since. The position peaked at $29.4M in Q1 2026. 612 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Invenomic Capital Management held 220,493 shares of Ingredion worth $20.9M as of Q2 2026.
  • Invenomic Capital Management sold 40,178 Ingredion shares in Q2 2026, an estimated $4.25M.
  • Ingredion made up 1.25% of Invenomic Capital Management's portfolio in Q2 2026, its #27 holding.
  • Invenomic Capital Management first reported a position in Ingredion in Q1 2022 and has held it in 5 quarters since.
  • Invenomic Capital Management's Ingredion position peaked at $29.4M in Q1 2026.
  • 612 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.